LI

Liando Investment

Europe, England, United Kingdom, London

Description

Liando Group is an investment company that provides investment management and consulting, as well as real estate development businesses.

Investor Profile

Liando Investment has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).

Stage Focus

  • Series B (33%)
  • Series C (33%)
  • Series Unknown (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Life Science
  • Robotics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Liando Investment frequently co-invest with?

ZS
Asia, Beijing, China, Beijing
Co-Investments: 1
Joy Capital
Asia, Beijing, China, Changyang
Co-Investments: 1
Sinovation Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
Prosperity Investment
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
Bosch Ventures
Europe, Baden-Wurttemberg, Germany, Stuttgart
Co-Investments: 1

What are some of recent deals done by Liando Investment?

LYNK Pharmaceuticals

Hangzhou, Zhejiang, China

LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.

BiotechnologyHealth CarePharmaceutical
Series CMay 31, 2023
Amount Raised: $28,122,276
Hsmap

Hangzhou, Zhejiang, China

Hsmap is a medical innovation and entrepreneurship big data platform.

Health Care
Series UnknownJun 12, 2022
MegaRobo

Beijing, Beijing, China

MegaRobo is an AI and robotics company that specializes in the fields of life sciences, clinical diagnosis, and applied chemistry.

Artificial Intelligence (AI)BiotechnologyLife ScienceRobotics
Series BNov 3, 2020
Amount Raised: $30,000,000